Rhythm Pharmaceuticals Stock Probability of Future Stock Price Finishing Over 54.88
Rhythm Pharmaceuticals' future price is the expected price of Rhythm Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Rhythm Pharmaceuticals performance during a given time horizon utilizing its historical volatility. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Please specify Rhythm Pharmaceuticals' target price for which you would like Rhythm Pharmaceuticals odds to be computed.
Rhythm |
Rhythm Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Rhythm Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Rhythm Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Rhythm Pharmaceuticals is not yet fully synchronised with the market data | |
| Rhythm Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Rhythm Pharmaceuticals had very high historical volatility over the last 90 days | |
| Rhythm Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 77.43 M. Net Loss for the year was (184.68 M) with profit before overhead, payroll, taxes, and interest of 21.5 M. | |
| Rhythm Pharmaceuticals currently holds about 235.6 M in cash with (136.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.64. | |
| Rhythm Pharmaceuticals has a poor financial position based on the latest SEC disclosures | |
| Over 99.0% of the company shares are owned by institutional investors |
Rhythm Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Rhythm Stock often depends not only on the future outlook of the current and potential Rhythm Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Rhythm Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 57.7 M | |
| Cash And Short Term Investments | 275.8 M |
Rhythm Pharmaceuticals Technical Analysis
Rhythm Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Rhythm Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Rhythm Pharmaceuticals. In general, you should focus on analyzing Rhythm Stock price patterns and their correlations with different microeconomic environments and drivers.
Rhythm Pharmaceuticals Predictive Forecast Models
Rhythm Pharmaceuticals' time-series forecasting models is one of many Rhythm Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Rhythm Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Rhythm Pharmaceuticals
Checking the ongoing alerts about Rhythm Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Rhythm Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Rhythm Pharmaceuticals is not yet fully synchronised with the market data | |
| Rhythm Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Rhythm Pharmaceuticals had very high historical volatility over the last 90 days | |
| Rhythm Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 77.43 M. Net Loss for the year was (184.68 M) with profit before overhead, payroll, taxes, and interest of 21.5 M. | |
| Rhythm Pharmaceuticals currently holds about 235.6 M in cash with (136.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.64. | |
| Rhythm Pharmaceuticals has a poor financial position based on the latest SEC disclosures | |
| Over 99.0% of the company shares are owned by institutional investors |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Tools for Rhythm Stock
When running Rhythm Pharmaceuticals' price analysis, check to measure Rhythm Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rhythm Pharmaceuticals is operating at the current time. Most of Rhythm Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Rhythm Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rhythm Pharmaceuticals' price. Additionally, you may evaluate how the addition of Rhythm Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |